Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant.

Although the primary end point did not reach statistical significance, the application of a logistic regression model that controlled for varying covariates at baseline did show statistical significance ( P = 0.0473).

also in 111,027 other papers

A numerical trend was evident in the subgroup of patients with the Delta variant (3.56 [2.19] and 3.97 [3.94] days, respectively).

also in 1,012 other papers